| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |